en
E-mail us
cn
Solid-State NMR (ssNMR) Analysis
Unambiguous Structural Characterization for APIs and Drug Products

Solid-state NMR (ssNMR) spectroscopy enables detailed structural characterization of APIs and drug products in the solid phase, providing critical insights into molecular structure, intermolecular interactions, and solid-form behavior that are not accessible through solution-based techniques.

Core ssNMR Characterization Capabilities

Solid-state NMR analysis provides direct insight into the structural and physicochemical properties of pharmaceutical solids, supporting identification and differentiation of:

Polymorphs and solid-state forms

Salt forms and counterion interactions

Solvates and hydrates

Amorphous and crystalline dispersions

Advanced ssNMR Analytical Techniques

A comprehensive suite of multidimensional and relaxation-based ssNMR techniques enables detailed structural and dynamic characterization of solid-state systems:
1D NMR (Line Shape Analysis)

Evaluates local chemical environments and detects structural heterogeneity, including polymorphic transitions and amorphous content.

2D NMR (Correlation Spectroscopy)

Reveals molecular connectivity and intermolecular interactions within and across crystal lattices, supporting detailed structural assignment.

Relaxation Measurements (T1/T2)

Quantifies molecular mobility and dynamics, enabling characterization of APIs, intermediates, drug products, and excipients in different solid states.

Versatile Nuclei Targeting for Solid-State Analysis

Advanced ssNMR techniques enable high-resolution analysis across multiple nuclei, providing comprehensive structural insights:

  • MAS and High-Power Decoupling (CP-MAS): Enhances spectral resolution and simplifies complex solid-state spectra for accurate interpretation.
  • Fluorine (¹⁹F) NMR: Highly sensitive detection for fluorinated compounds, enabling differentiation of polymorphs and amorphous phases.
  • Phosphorus (³¹P) NMR: Specialized applications for phosphorus-containing compounds and solid-state formulations.

Efficient Sample Utilization & High Sensitivity

Solid-state NMR supports quantitative and high-sensitivity analysis across a wide range of sample conditions:

  • Reliable results achieved with sample quantities ranging from milligrams to low hundreds of milligrams
  • Flexible optimization of limits of detection (LOD) and quantification (LOQ) based on sample characteristics
  • Enhanced signal-to-noise ratios through advanced acquisition strategies and optimized experimental conditions

Advancing Solid-State Understanding in Drug Development

Solid-state NMR (ssNMR) plays a critical role in pharmaceutical development by providing detailed structural and dynamic insights that support solid-form selection, formulation development, and product stability assessment.

From early-stage characterization through commercial development, ssNMR enables informed decision-making and reduces solid-state risks across the drug development lifecycle.

Achieve Your Success with Our Expertise

Have a question or need support with your project? Please complete the form, and our team will get back to you shortly.




Our capabilities span three specialized platforms:

  • Small Molecule

  • Crystal Bio Solutions

  • Crystal NAX


By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.

Small Molecule Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Crystal NAX
DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products
Contact Us
bd_global@crystalpharmatech.com (925) 558-5040
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Floor 1, Bldg. 3, 68 Chunpu Road, Suzhou Industrial Park, Suzhou, China 215123
Subscribe to be the first to get the updates!

Subscribe to be the first to get the updates!

NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com (925) 558-5040